Proteome Sciences' 2011 Revenues Climb Sharply | GenomeWeb

NEW YORK (GenomeWeb News) – Proteome Sciences preliminarily reported Tuesday that its revenues more than doubled year over year for full-year 2011.

For the year ended Dec. 31, 2011, the UK company recorded revenues of £1.0 million ($1.6 million), up from £450,088 for full-year 2010. The 2010 figure excludes the exceptional £9.5 million in income from the Sanofi-Aventis warranty claim settlement, Proteome Sciences said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.